IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Gene Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

4.31

h-Index

2024-2025

 177

Rank

2024-2025

 1760

SJR

2024-2025

 1.784

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Gene Therapy
Abbreviation Gene Ther.
Publication Type Journal
Subject Area, Categories, Scope Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)
h-index 177
Overall Rank/Ranking 1760
SCImago Journal Rank (SJR) 1.784
Impact Score 4.31
Publisher Springer Nature
Country United Kingdom
ISSN 09697128, 14765462
Best Quartile Q1
Coverage History 1994-2025




About Gene Therapy


Gene Therapy is a journal covering the technologies/fields/categories related to Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). It is published by Springer Nature. The overall rank of Gene Therapy is 1760. According to SCImago Journal Rank (SJR), this journal is ranked 1.784. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 177. The best quartile for this journal is Q1.

The ISSN of Gene Therapy journal is 09697128, 14765462. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Gene Therapy is cited by a total of 1179 articles during the last 3 years (Preceding 2024).


Gene Therapy Impact IF 2024-2025


The Impact IF 2024 of Gene Therapy is 4.31, which is computed in 2025 as per its definition. Gene Therapy IF is decreased by a factor of 1.02 and approximate percentage change is -19.14% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Gene Therapy Impact IF 2025 Prediction


Impact IF 2024 of Gene Therapy is 4.31. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Gene Therapy. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 4.31
2023 5.33
2022 4.62
2021 3.46
2020 3.62
2019 3.80
2018 3.37
2017 3.17
2016 3.21
2015 3.74
2014 3.74

Gene Therapy h-index


  Table Setting

Gene Therapy has an h-index of 177. It means 177 articles of this journal have more than 177 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Gene Therapy ISSN


The ISSN of Gene Therapy is 09697128, 14765462. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Gene Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Gene Therapy is 1760. According to SCImago Journal Rank (SJR), this journal is ranked 1.784. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Gene Therapy by Year


Year SJR
2025/2026 Coming Soon
2024 1.784
2023 1.671
2022 1.366
2021 0.927
2020 1.332
2019 1.340
2018 1.313
2017 1.277
2016 1.421
2015 1.536
2014 1.527

Ranking of Gene Therapy by Year


Year Ranking
2025/2026 Coming Soon
2024 1760
2023 1860
2022 2496
2021 4580
2020 2748
2019 2715
2018 2849
2017 3009
2016 2593
2015 2280
2014 2231

Gene Therapy Publisher


Table Setting

Gene Therapy is published by Springer Nature. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Gene Therapy is Gene Ther.. This abbreviation ('Gene Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Gene Therapy


If your research field is/are related to Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Gene Therapy?

Gene Therapy latest impact IF is 4.31. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 5.33 (2023) and 3.17 (2017), respectively, in the last 11 years. Moreover, its average IS is 3.85 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Gene Therapy?

The Gene Therapy has an SJR (SCImago Journal Rank) of 1.784, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.784 in 2024 and the lowest being 0.927 in 2021. Furthermore, the average SJR of the Gene Therapy over the previous 11-year period stands at 3.85.


What's the latest h-index of the Gene Therapy?

The latest h-index of the Gene Therapy is 177.


Who's the publisher of the Gene Therapy?

The Gene Therapy is published by the Springer Nature, with its country of publication being the United Kingdom.


What's the current ranking of the Gene Therapy?

The Gene Therapy is currently ranked 1760 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1760 in 2024 and its lowest position of 4580 in 2021.


What's the abbreviation or short name for the Gene Therapy?

The standard ISO4 abbreviation for the Gene Therapy is Gene Ther..


Is the "Gene Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Gene Therapy is classified as a journal that the Springer Nature publishes.


What's the scope or major areas of the Gene Therapy?

The Gene Therapy encompasses the following areas:

  • Genetics
  • Molecular Biology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Gene Therapy?

The Gene Therapy is assigned the following International Standard Serial Numbers (ISSN): 09697128, 14765462.


What's the best quartile of the Gene Therapy?

The best quartile for the Gene Therapy is Q1 (2024).


What's the coverage history of the Gene Therapy?

The Gene Therapy coverage history can be summarized as follows: 1994-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Business Finance and Accounting journal 3244 Wiley-Blackwell Publishing Ltd 96 3.34
Journal of Applied Business Research journal 26260 Clute Institute 33 0.17
Journal of Classical Sociology journal 16960 SAGE Publications Ltd 31 0.68
Child and Family Social Work journal 8793 Wiley-Blackwell Publishing Ltd 78 2.42
International Journal of Parallel, Emergent and Distributed Systems journal 17452 Taylor and Francis Ltd. 27 1.17
Modern Language Journal journal 1033 Wiley-Blackwell 123 3.95
Journal of Sociolinguistics journal 4415 Wiley-Blackwell Publishing Ltd 68 2.14
Howard Journal of Communications journal 14582 Taylor and Francis Ltd. 42 1.27
Libyan Studies journal 21508 Cambridge University Press 10 0.14
Epigenetics journal 4304 Taylor and Francis Ltd. 117 3.37

Check complete list




Year wise Impact Score (IS) of Gene Therapy

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 4.31
2023 5.33
2022 4.62
2021 3.46
2020 3.62
2019 3.80
2018 3.37
2017 3.17
2016 3.21
2015 3.74
2014 3.74



Top Journals/Conferences in Genetics

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Genetics
Nature Research | United Kingdom

Nature Reviews Genetics
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Cell Stem Cell
Cell Press | United States

Nucleic Acids Research
Oxford University Press | United Kingdom

Nature Microbiology
Nature Research | United Kingdom

Annual Review of Medicine
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Research | United Kingdom

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Methods
Nature Research | United Kingdom

Nature Reviews Genetics
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Physiological Reviews
American Physiological Society | United States

Cell Metabolism
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cell
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Research | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

EMBO Molecular Medicine
Springer Science and Business Media Deutschland GmbH | United Kingdom

See All